Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults (Q37608302)

21 August 2017

1 reference

title

Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults (English)

1 reference

21 August 2017

1 reference

1 reference

Li-Min Huang

0 references

Yhu-Chering Huang

1 reference

21 August 2017

Wen-Chen Li

1 reference

21 August 2017

Tsung-Zu Wu

series ordinal

1 reference

21 August 2017

publication date

1 October 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

1317-1327

1 reference

Microbiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens

21 August 2017

cites work

1 reference

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

21 January 2018

1 reference

Mechanisms of Bordetella pathogenesis

21 January 2018

1 reference

Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease

21 January 2018

1 reference

Health burden of pertussis in infants and children

21 January 2018

1 reference

Health burden of pertussis in adolescents and adults

21 January 2018

1 reference

Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives

21 January 2018

1 reference

Clinical practice. Pertussis--not just for kids

21 January 2018

1 reference

Epidemiology of pertussis

21 January 2018

1 reference

What is new in pertussis?

21 January 2018

1 reference

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

21 January 2018

1 reference

The science and fiction of the "resurgence" of pertussis.

21 January 2018

1 reference

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents

21 January 2018

1 reference

Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents

21 January 2018

1 reference

Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies

21 January 2018

1 reference

Frequency of unrecognized Bordetella pertussis infections in adults.

21 January 2018

1 reference

Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997.

21 January 2018

1 reference

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

21 January 2018

1 reference

Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model

21 January 2018

1 reference

Pertussis sources of infection and routes of transmission in the vaccination era.

21 January 2018

1 reference

Severe and unrecognised: pertussis in UK infants

21 January 2018

1 reference

Summary: epidemiology of pertussis

21 January 2018

1 reference

Prevalence and incidence of adult pertussis in an urban population

21 January 2018

1 reference

Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine

21 January 2018

1 reference

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

21 January 2018

1 reference

Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents

21 January 2018

1 reference

Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

21 January 2018

1 reference

Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults

21 January 2018

1 reference

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents

21 January 2018

1 reference

Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

21 January 2018

1 reference

Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation

21 January 2018

1 reference

Cellular immunity in adolescents and adults following acellular pertussis vaccine administration

21 January 2018

1 reference

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

21 January 2018

1 reference

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

21 January 2018

1 reference

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

21 January 2018

1 reference

Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data

21 January 2018

1 reference

Cost-effectiveness of adult pertussis vaccination in Germany

21 January 2018

1 reference

Cost effectiveness of pertussis vaccination in adults

21 January 2018

1 reference

Economic considerations for pertussis booster vaccination in adolescents

21 January 2018

1 reference

Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada

21 January 2018

1 reference

Pertussis vaccination for adolescents and adults

21 January 2018

1 reference

Clinical and economic effects of pertussis outbreaks

21 January 2018

1 reference

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

21 January 2018

1 reference

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.96

1 reference

21 August 2017

1 reference